THOMAS JACKSON: Open Payments
NPI 1528262698 · SULLIVAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 25 payments from 14 companies in 2025. Trend: 2023 $1,104 · 2024 $1,474 · 2025 $451
Food & beverage: $374Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $140 |
| Lundbeck LLC | 2 | $77 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: REXULTI, QULIPTA, VRAYLAR, Auvelity, TREMFYA, TZIELD, MOUNJARO, Ozempic.
Industry payments across MO — which companies pay providers there.
